Gut

Journal PubWeight™ 16829.79‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. 2012 12.62
2 Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. 1960 12.55
3 Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. 2005 10.95
4 Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. 2012 10.56
5 The risk of colorectal cancer in ulcerative colitis: a meta-analysis. 2001 10.07
6 The Vienna classification of gastrointestinal epithelial neoplasia. 2000 9.39
7 Increased expression of interleukin 17 in inflammatory bowel disease. 2003 9.16
8 Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. 2006 9.03
9 Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. 2009 8.98
10 A ne method for studying gut transit times using radioopaque markers. 1969 8.97
11 Endoscopic mucosal resection for treatment of early gastric cancer. 2001 8.70
12 THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS. 1964 8.63
13 The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. 2006 8.08
14 Functional bowel disorders and functional abdominal pain. 1999 7.63
15 Rectal biopsy as an aid to cancer control in ulcerative colitis. 1967 7.39
16 Epidemiology of gastro-oesophageal reflux disease: a systematic review. 2005 7.35
17 Intestinal spirochaetosis. 1971 7.31
18 THE INTRALUMINAL PRESSURE PATTERNS IN DIVERTICULOSIS OF THE COLON. I. RESTING PATTERNS OF PRESSURE. II. THE EFFECT OF MORPHINE. 1964 7.25
19 Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. 1999 7.14
20 Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. 1988 7.03
21 Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. 1997 6.96
22 CROHN'S DISEASE OF THE LARGE INTESTINE. 1964 6.92
23 THE CONSTITUTION AND PROPERTIES OF TWO GASTRINS EXTRACTED FROM HOG ANTRAL MUCOSA. 1964 6.71
24 Short chain fatty acids in human large intestine, portal, hepatic and venous blood. 1987 6.61
25 The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. 2009 6.50
26 Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. 2009 6.50
27 Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). 2010 6.34
28 THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. 1963 6.34
29 CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. 2008 6.26
30 Quantitation of intraepithelial lymphocytes in human jejunum. 1971 6.18
31 Intestinal reticulosis as a complication of idiopathic steatorrhoea. 1962 6.16
32 A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). 1973 6.09
33 Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. 2011 6.08
34 A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? 2004 5.97
35 Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? 2008 5.86
36 Hepatocellular carcinoma: clinical frontiers and perspectives. 2014 5.79
37 The Oslo definitions for coeliac disease and related terms. 2012 5.76
38 Studies of basal and peak acid output with an augmented histamine test. 1963 5.59
39 Malignancy in coeliac disease--effect of a gluten free diet. 1989 5.58
40 Ischaemic colitis. 1966 5.51
41 Non-colonic features of irritable bowel syndrome. 1986 5.48
42 Guidelines for the management of inflammatory bowel disease in adults. 2011 5.42
43 Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. 2005 5.39
44 Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. 2004 5.32
45 An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. 1965 5.25
46 TREATMENT OF GASTRIC ULCER WITH CARBENOXOLONE SODIUM AND OESTROGENS. 1965 5.25
47 Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. 2005 5.20
48 Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. 2003 5.19
49 New clinical method for measuring the rate of gastric emptying: the double sampling test meal. 1968 5.18
50 Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. 1977 5.12
Next 50